Skip to main content

Table 4 Scheme of immunization of animals with recombinant influenza A viruses of the subtypes Н5N1 and H1N1

From: Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection

Species

Viral construct

Route of administration

Number of animals

Prime vaccination dose (Н5N1), Log10EID50/animal

Boost vaccination dose (Н1N1), Log10EID50/animal

Mice

Monovalent Flu-NS1-124-L7/L12

i.n.

10

5.97

6.39

c.

10

5.58

6.08

s.c.

10

6.58

7.00

Monovalent Flu-NS1-124-Omp16

i.n.

10

5.51

5.64

c.

10

5.20

5.33

s.c.

10

6.12

6.25

Bivalent vaccine formulation Flu-NS1-124-L7/L12 + Flu-NS1-124-Omp16

i.n.

10

5.58 + 5.20

6.08 + 5.33

c.

10

5.27 + 4.89

5.69 + 4.99

s.c.

10

6.27 + 5.81

6.69 + 5.94

Guinea pigs

Monovalent Flu-NS1-124-L7/L12

i.n.

5

6.28

6.70

c.

5

5.89

6.39

s.c.

5

6.58

7.00

Monovalent Flu-NS1-124-Omp16

i.n.

5

5.82

5.95

c.

5

5.51

5.64

s.c.

5

6.12

6.25

Bivalent vaccine formulation Flu-NS1-124-L7/L12 + Flu-NS1-124-Omp16

i.n.

5

5.97 + 5.51

6.39 + 5.64

c.

5

5.58 + 5.20

6.00 + 5.30

s.c.

5

6.27 + 5.81

6.69 + 5.94

  1. The amounts of inoculate for the intranasal (i.n.), conjunctival (c.) or subcutaneous (s.c.) immunization routes were 50, 25, and 200 μl for mice, and 100, 50 and 200 μl for guinea pigs, respectively.